Estrella Immunopharma ESLA
NASDAQ ESLA
$0.71 +0.16 (+28.89%)
As of: Oct 22, 2026 · 2:23 PM EDT

Estrella Immunopharma (ESLA) Non-Current Deferred Tax Liability (2022 - 2023)

Updated

Estrella Immunopharma's Non-Current Deferred Tax Liability came in at $8,370 for FY2023.

Analysis

Estrella Immunopharma (ESLA) Non-Current Deferred Tax Liability (2022 - 2023) Analysis & Trends

  • Per Business Quant, earlier years put Non-Current Deferred Tax Liability at $29,472 in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,171.23 Bn 1,139.82 Bn 19.71 Bn
2 Johnson & Johnson 648.76 Bn 568.62 Bn 17.30 Bn
3 AbbVie 503.78 Bn 476.89 Bn 12.70 Bn
4 Merck 366.20 Bn 320.58 Bn 12.21 Bn
5 Novartis Ag 303.55 Bn 267.54 Bn 11.24 Bn
6 Astrazeneca 269.42 Bn 243.11 Bn 12.86 Bn
7 Amgen 242.43 Bn 197.83 Bn 7.24 Bn
8 Gilead Sciences 195.01 Bn 169.21 Bn 6.22 Bn
9 Pfizer 172.42 Bn 119.07 Bn 10.94 Bn
10 Estrella Immunopharma 30.57 Mn 25.49 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 8,370.00
Mar 31, 2023 7,772.00
Dec 31, 2022 29,472.00
API Access

Estrella Immunopharma Non-Current Deferred Tax Liability API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-deferred-tax-liability&ticker=ESLA&period=max&api_key=YOUR_API_KEY